Troels Bechmann

690 total citations
30 papers, 458 citations indexed

About

Troels Bechmann is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Troels Bechmann has authored 30 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Troels Bechmann's work include HER2/EGFR in Cancer Research (12 papers), Breast Cancer Treatment Studies (8 papers) and Cancer Treatment and Pharmacology (6 papers). Troels Bechmann is often cited by papers focused on HER2/EGFR in Cancer Research (12 papers), Breast Cancer Treatment Studies (8 papers) and Cancer Treatment and Pharmacology (6 papers). Troels Bechmann collaborates with scholars based in Denmark, United States and Finland. Troels Bechmann's co-authors include Jonna Skov Madsen, Karina Dahl Steffensen, Erik Jakobsen, Ivan Brandslund, Angela Coulter, Pernille Tine Jensen, Kent Søe, Jean‐Marie Delaissé, Anaïs Marie Julie Møller and Luísa Matos do Canto and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Troels Bechmann

28 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Troels Bechmann Denmark 13 217 130 113 89 67 30 458
Lindsay Carlsson Canada 9 324 1.5× 73 0.6× 215 1.9× 126 1.4× 59 0.9× 25 667
Anne S. Quante Germany 12 369 1.7× 213 1.6× 117 1.0× 94 1.1× 22 0.3× 30 695
Cecilia Yee United States 14 280 1.3× 74 0.6× 69 0.6× 313 3.5× 46 0.7× 19 614
D. Serin France 15 759 3.5× 72 0.6× 375 3.3× 127 1.4× 47 0.7× 73 1.2k
Ian Campbell New Zealand 16 448 2.1× 49 0.4× 380 3.4× 89 1.0× 85 1.3× 60 709
Katherine Enright Canada 10 412 1.9× 119 0.9× 216 1.9× 138 1.6× 31 0.5× 36 627
Demetrios Simos Canada 11 178 0.8× 46 0.4× 138 1.2× 58 0.7× 105 1.6× 25 337
E. Greer Gay United States 7 247 1.1× 109 0.8× 85 0.8× 322 3.6× 62 0.9× 10 680
Nicola Roche United Kingdom 8 315 1.5× 51 0.4× 285 2.5× 68 0.8× 49 0.7× 18 629
Nancy Watroba United States 13 387 1.8× 74 0.6× 263 2.3× 75 0.8× 32 0.5× 16 588

Countries citing papers authored by Troels Bechmann

Since Specialization
Citations

This map shows the geographic impact of Troels Bechmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Troels Bechmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Troels Bechmann more than expected).

Fields of papers citing papers by Troels Bechmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Troels Bechmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Troels Bechmann. The network helps show where Troels Bechmann may publish in the future.

Co-authorship network of co-authors of Troels Bechmann

This figure shows the co-authorship network connecting the top 25 collaborators of Troels Bechmann. A scholar is included among the top collaborators of Troels Bechmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Troels Bechmann. Troels Bechmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bechmann, Troels, Mette Holck Nielsen, Signe Timm, et al.. (2024). Shared decision making with breast cancer patients – does it work? Results of the cluster-randomized, multicenter DBCG RT SDM trial. Radiotherapy and Oncology. 193. 110115–110115. 4 indexed citations
2.
Berg, Tobias, Maj‐Britt Jensen, Maria Rossing, et al.. (2024). Development and Methodological Validation of a Modified Staging System for de Novo Metastatic Breast Cancer. JAMA Network Open. 7(3). e242174–e242174. 4 indexed citations
3.
Andersen, Rikke Fredslund, et al.. (2024). Circulating methylated HOXA9 tumor DNA as a biomarker for mortality in recurrent breast cancer: An exploratory study. Oncology Letters. 28(6). 581–581. 2 indexed citations
4.
Kahns, Søren, Signe Timm, Rikke Fredslund Andersen, et al.. (2023). Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA. Scientific Reports. 13(1). 8419–8419. 12 indexed citations
5.
Tan, Qihua, Anaïs Marie Julie Møller, Chuan Qiu, et al.. (2023). A variability in response of osteoclasts to zoledronic acid is mediated by smoking-associated modification in the DNA methylome. Clinical Epigenetics. 15(1). 42–42. 3 indexed citations
6.
Hansen, Torben Frøstrup, et al.. (2023). Circulating methylated-HOXA9 tumor DNA as a biomarker for mortality in recurrent breast cancer.. Journal of Clinical Oncology. 41(16_suppl). e13106–e13106.
7.
Bechmann, Troels, et al.. (2021). ePRO-based individual follow-up care for women treated for early breast cancer: impact on service use and workflows. Journal of Cancer Survivorship. 15(4). 485–496. 16 indexed citations
8.
Møller, Anaïs Marie Julie, et al.. (2020). Zoledronic Acid Is Not Equally Potent on Osteoclasts Generated From Different Individuals. JBMR Plus. 4(11). e10412–e10412. 19 indexed citations
9.
Offersen, Birgitte Vrou, Troels Bechmann, Axel Cosmus Pyndt Diederichsen, et al.. (2020). Delineation of whole heart and substructures in thoracic radiation therapy: National guidelines and contouring atlas by the Danish Multidisciplinary Cancer Groups. Radiotherapy and Oncology. 150. 121–127. 50 indexed citations
10.
Møller, Anaïs Marie Julie, Jean‐Marie Delaissé, Jonna Skov Madsen, et al.. (2020). Aging and menopause reprogram osteoclast precursors for aggressive bone resorption. University of Southern Denmark Research Portal (University of Southern Denmark). 72 indexed citations
11.
Madsen, Poul Henning, et al.. (2020). The impact of shared decision making on time consumption and clinical decisions. A prospective cohort study. Patient Education and Counseling. 104(7). 1560–1567. 25 indexed citations
12.
Olsen, Dorte Aalund, Ivan Brandslund, Troels Bechmann, et al.. (2020). Prognostic impact of serum levels of EGFR and EGFR ligands in early-stage breast cancer. Scientific Reports. 10(1). 16558–16558. 9 indexed citations
13.
Olsen, Dorte Aalund, Ivan Brandslund, Troels Bechmann, et al.. (2020). Dysregulated EGFR pathway in serum in early-stage breast cancer patients: A case control study. Scientific Reports. 10(1). 6714–6714. 7 indexed citations
14.
Olsen, Dorte Aalund, et al.. (2019). EGFR and EGFR ligands in serum in healthy women; reference intervals and age dependency. Clinical Chemistry and Laboratory Medicine (CCLM). 57(12). 1948–1955. 9 indexed citations
15.
Bechmann, Troels, et al.. (2019). <p>Are patient-reported outcomes useful in post-treatment follow-up care for women with early breast cancer? A scoping review</p>. Patient Related Outcome Measures. Volume 10. 117–127. 25 indexed citations
16.
Bechmann, Troels, Poul Henning Madsen, Erik Jakobsen, et al.. (2018). DEVELOPMENT OF A PATIENT DECISION AID TEMPLATE FOR USE IN DIFFERENT CLINICAL SETTINGS. University of Southern Denmark Research Portal (University of Southern Denmark). 14 indexed citations
17.
Bechmann, Troels, Dorte Aalund Olsen, Erik Jakobsen, et al.. (2013). Quantitative detection of HER2 protein concentration in breast cancer tissue does not increase the number of patients eligible for adjuvant HER2-targeted therapy. Oncology Reports. 29(4). 1475–1482. 5 indexed citations
18.
Bechmann, Troels, Rikke Fredslund Andersen, Niels Pallisgaard, et al.. (2013). Plasma HER2 amplification in cell-free DNA during neoadjuvant chemotherapy in breast cancer. Journal of Cancer Research and Clinical Oncology. 139(6). 995–1003. 24 indexed citations
19.
Bechmann, Troels, Jonna Skov Madsen, Ivan Brandslund, et al.. (2013). Predicting brain metastases of breast cancer based on serum S100B and serum HER2. Oncology Letters. 6(5). 1265–1270. 9 indexed citations
20.
Bechmann, Troels, et al.. (2012). Increased concentrations of growth factors and activation of the EGFR system in breast cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 50(10). 1809–18. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lindsay Carlsson Breakdown of academic impact, for papers by Anne S. Quante Breakdown of academic impact, for papers by Cecilia Yee Breakdown of academic impact, for papers by D. Serin Breakdown of academic impact, for papers by Ian Campbell Breakdown of academic impact, for papers by Katherine Enright Breakdown of academic impact, for papers by Demetrios Simos Breakdown of academic impact, for papers by E. Greer Gay Breakdown of academic impact, for papers by Nicola Roche Breakdown of academic impact, for papers by Nancy Watroba
Rankless by CCL
2026